Results 201 to 210 of about 84,389 (260)

MicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis - A functional characterization. [PDF]

Curr Allergy Asthma Rep
Przychodniak D, Jankowski WM, Kurowski M.   +2 more
europepmc   +1 more source

Nematodes immunomodulatory mechanisms and possible clinical application. [PDF]

Front Immunol
Świderski N, Gumienny M, Bielecka-Wajdman A.   +2 more
europepmc   +1 more source

Chlorogenic Acid Alleviates Experimental Asthma by Reprogramming DHA Metabolism to Inhibit Ferroptosis. [PDF]

Int J Mol Sci
Zhou P, Abudukeremu G, Zhang ZL, Xu JY, Ji JX, Guo YD, Zhang MX, Ren L, Wang LL, Tang ZC, Wotan A, Rong XJ, Tie C, Gao TL.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Newer Anti-Allergic Agents

Medical Clinics of North America, 1961
exaly   +4 more sources

The effect of the anti-allergic agent avil on abnormal scar fibroblasts

Burns, 1999
Abnormal wound healing in humans leads to the formation of hypertrophic scar and keloids. These abnormal scars accumulate excessive extracellular matrix proteins through increased synthesis as well as decreased degradation. In order to find a therapeutic control for scar formation, we investigated the effect of avil (pheniramine maleate) on fibroblasts
J, Venugopal, M, Ramakrishnan, C M, Habibullah, M, Babu   +3 more
openaire   +2 more sources

P2X7 receptor antagonist activity of the anti-allergic agent oxatomide

European Journal of Pharmacology, 2015
Activation of the P2X7 receptor by extracellular ATP is associated with various immune responses including allergic inflammation. Anti-allergic agents, such as H1-antihistamines, are known to inhibit the effects of different chemical mediators such as acetylcholine and platelet-activating factor.
Kazuki, Yoshida, Masaaki, Ito, Isao, Matsuoka   +2 more
openaire   +2 more sources

Clinical investigation of agents with prophylactic anti‐allergic effects in bronchial asthma*

Clinical & Experimental Allergy, 1978
SummaryTo determine the efficacy of ketotifen as an oral anti‐asthmatic agent, experimental and therapeutic long‐term trials were carried out. Four models were used in the experimental therapeutic trials and the antihislaminic agent clemastine and disodium cromoglycate were used as comparative substances.
L, Craps, C, Greenwood, P, Radielovic
openaire   +2 more sources